outcomes and sequences of target therapies in cll (chronic lymphocytic leukemia) - ash 2023
Published 4 months ago • 419 plays • Length 9:54Download video MP4
Download video MP3
Similar videos
-
4:57
sequencing of targeted therapies for cll
-
10:19
first-line treatment outcomes in patients with sll (small lymphocytic lymphoma) - ash 2023
-
12:53
selecting first-line treatment for chronic lymphocytic leukemia (cll)
-
1:37
acalabrutinib may be an alternative to ibrutinib for treatment of cll
-
2:22
igvh and other high-risk cytogenetic risk factors in cll
-
1:50
targeted therapy in cll in 2022 and in the future
-
9:48
optimal combination and sequence of chronic lymphocytic leukemia therapies
-
21:19
cll: sequencing monotherapy vs. combination therapy
-
5:51
sequencing targeted therapies in cll after intolerance versus progression
-
1:49
what are the benefits of having different chronic lymphocytic leukemia (cll) treatment options?
-
1:33
future advancements in the treatment of cll
-
4:26
advances in the molecular stratification of chronic lymphocytic leukemia
-
1:29
the importance of treatment sequencing in cll
-
2:09
ash highlights in cll: moving towards fixed-duration treatment, the role of mrd & alpine results
-
1:36
the utility of mrd for predicting treatment outcomes in patients with cll
-
9:00
overview of cll therapies and sequencing of therapies
-
3:58
btk-targeted therapy for cll
-
28:33
icaho19 - lymphoid malignancies: sequencing therapies in cll
-
4:18
treatment options for chronic lymphocytic leukemia (cll)